Beyond Meats future is here (the TWLO chart) - BYNDEverything is on the chart. $BYND #BYND BYND has offered 3.250 million shares after hottest IPO of the year.
Here is how same affected Twilio back then
IPO
Alex Vieira Reiterates Beyond Meat STRONG BUY Price Target $203Beyond Meat best IPO to invest in 2019
CrowdStrike 1st time earnings Another of the IPO's I really like this year is CRWD, they will report earnings for the first time this Thursday.
Most analysts have a buy rating, with a price target 90$-100$. Meaning 12.5%-25% potential upside.
Revolve will establish new channelRevolve has had a rocky time since its IPO, with lots of volatility and several breaks below critical trend lines. However, this company is profitable, undervalued, and highly rated, and in my opinion it's still a great value.
With Revolve having breached the bottom of its parallel channel today, it's likely to establish a new channel. I've drawn a couple possible channels and some trend lines, and I've marked the breakout zones with the play for each zone. I've also marked support and resistance from all-time highs, and you can also see the high-volume support node at 35.27.
Currently I'm playing this long on the basis of that volume support node.
RVLV testing channel bottomToday looks like a good entry on RVLV, with the price testing the bottom of its parallel channel. RVLV also has a volume support node at 35.27 and is close to oversold on the RSI. We just got an upward stochastic cross as well.
RVLV is undervalued and has bullish analyst ratings.
Stitch Fix poised for a turnaroundStitch Fix is at support from a high-volume node on the volume profile and from its 50-day moving average. It also has some RSI support around 38.
The stock just got some big analyst upgrades from Zacks and Goldman, which could serve as upside catalysts. The Internet retail sector is currently outperforming the S&P 500. S&P Capital IQ rates Stitch Fix as undervalued, with stable growth potential. Overall, both fundamentals and market sentiment are looking up for the stock.
However, Stitch Fix has some downward momentum, so it could fall through the 50-day MA before rebounding from 200-day MA support near 26. I don't expect it to fall any further than that, but in the worst-case scenario we could get as low as the high-volume node at 23.
ZOOM - Bullish analyst ratingOne of this year's hottest IPOs is still winning over new fans. Dmitry Netis at Stephens is initiating coverage of Zoom Video (ZM) with a bullish overweight rating .
The analyst's price target of $115 suggests that there's 26% of upside from current levels, an encouraging goal for the provider of video-conferencing solutions for enterprises that has already soared 153% since going public at $36 in April through Thursday's close.
---News reported by Rick Munarriz, The Motley Fool / Yahoo Finance
BYND - 15% Decline and Beyond ??? NASDAQ:BYND
Something I came across that normally would result in the suggested move...
Selling $175 with a move towards the previous pivot LO with possible continuation towards a gap close.
This would capture a nice 15%+ move.
Adaptive Biotechnology (MSFT & Genentech partner)"Microsoft and Adaptive Biotechnologies announce partnership using AI to decode immune system; diagnose, treat disease"
They also have a partnership with Genentech (January 2019)
ADPT - Adaptive Biotechnology
IPO: June 27th 2019 - open @$39 (above current price)
Vision: We aim to improve people’s lives by translating the scale and precision of their adaptive immune systems into products to help diagnose, treat, and monitor disease.
Great risk reward with an entry right now. If we break the IPO low @36.2, I would recommend exiting part of your position.
Happy trading!
dorfmanmaster
P.S:
I think this is a short-term, not to mention long-term good investment.
I recommend looking for their research on cellular therapy.
Akerna $KERN Coming In That Buy Zone. Fresh IPO (kind of).Akerna coming into that buy zone. Stock IPOed (actually it was a SPAC) at around $11 after doing their last private placement at $10.21. As this is a recent IPO (of sorts) and a cannabis company, I expect this will eventually shake out at 2x the IPO price (around $20) so buy on dips.
Why 2x IPO price? Look at high flyers Zoom $ZM, Beyond Meat $BYND, Crowdstrike $CRWD, all trading at about 2x IPO price, based on hype, growing markets, and sales growth.
Akerna is Cloud + Payments + Cannabis. They have an ERP software for cannabis supply chain / growers / dispensaries. All the buzzwords. Not sure 100% if the company has a legit future (need to do more research), but certainly I think this thesis is enough to put it on your watchlist.
BYND may recover late in the dayBeyond Meat is down today even though it posted strong sales numbers this morning. It's near trendline support and could recover somewhat in power hour today.
Beyond Meat - the new TLRYThis was the hottest IPO of 2019. Statistically it was totally out of the line with others. But it happened and I'm glad that I was in it
The company is fine and the product is great.
But the revenue and the growth pace need to find balance with the market value of the company.
As soon as greed ends and we move to lock up period end BYND should correct somehow.
The 3 month lock up period is on 2 August,
The 6 month lock up period is on 2 November.
Earnings support and Volume support holds near ~ $100. This will eventually revisit.
Selling short overnight price is around 300%/year , as soon as it settles - we will have the meltdown.
Good entry point for SlackLook to buy at support of 36.26, with current stop loss of 36.06. Move that stop loss up periodically to keep it just below the channel.
This is just an idea as to how the market will move, not investment advice.
Slack forms upward channelSlack looks like it's forming an upward channel after breakout from its previous downward one.
Beyond Meat is near trendline supportBeyond Meat should find some trendline support at its current price level. From there, we've got several longer-term trendlines that could slow its fall, and then solid support at 100 from historical volume. Given how overvalued the stock is, I'd hesitate to buy it unless it got down to at least the lowest long-term trendline, or better yet the volume support at 100.
RVLV trendline supportRevolve has formed am upward parallel channel since its IPO. It's currently in the bottom half of the channel, with support from a trendline that's parallel to its channel. So far we're looking good for a reversal upward tomorrow based on this trendline support. Set tight stops, however, in case we breach support and head downward to channel bottom. Then look to re-enter in the 31-32 range.
As always, this is just an idea as to how the market will move, not investment advice.
Transportation Clones / LevelsIn name and concept; clones
some people refer to fib levels colloquially as clones as well!
enjoy
manage your own risk
much love
gl hf
xoxo
snoop
$KERN a new bomb just dropped!Marijuana software company, the first of its kind! Let's see what happens here!
Float 768K
Chewy downward triangle breakout, at high volume supportChewy made a downward triangle breakout and will consolidate for a little while. It should find some support at this price level, which in the short time since its IPO has been a fairly high volume level. However, Chewy's fundamentals don't check out. It's an unprofitable company and doesn't appear to be making progress toward profitability. It may breach support and fall further.
Lyft at upward trend line, looking bullish toward top of channelLyft is in the middle of its upward-sloping channel, and this week it's been following an even steeper upward trend line toward the top of the channel. Right now it's at the trend line, looking bullish for late today and tomorrow.
Revolve approaching a decision point tomorrowRevolve has formed a triangle chart pattern since its IPO a few days ago. On upside breakout, look for confirmation above $41.61 resistance level. On a downside breakout, look for confirmation below $36.74 resistance level.
Tomorrow is a historically bullish date for stocks, so perhaps Revolve will break out upward simply on seasonality. Citron, the only analyst to opine on Revolve, has set a price target of $50. Downward consolidation is the alternative. In that scenario, Look for a slow slide down toward secondary resistance at 30.65 as the price consolidates before its next upward gap.
TUFN Q1 Earnings TUFN is a recent IPO that interest me. Revenues growing 30% Y/Y. Has captured 15% of Global 2000 companies. Retains 70%-75% of its customers and now has $100 million cash from the IPO. Last year 60% of revenue was from existing customers. Thinking they can really increase sales with new cash. Management team consist of a couple of guys from CHKP ($17b market cap). I don’t have a position but watching, Q1 earnings are Thursday. 2017-2018 Q/Q revenue growth 45%. As far as product, company has a few things it needs to workout. Cyber Security is a tough and TUFN seems to have internal pressure to perform which is normal for a growing company trying to capture a significant share of the market. May or may not try a small position this week but will be watching.
Side note: kinda has a tiny float so good earnings and fresh breakout over $25 could probably run to low $30s people love buying anything that is going up.
As always do your own research. Not investment advice.
